KorrekturOpen Access
Correction: Aloeemodin as drug candidate for cancer therapy
Oncotarget · 06.01.2026 · 17 (1) · 214-215
DOI: 10.18632/oncotarget.28870 ↗Kurz gefasst
Korrektur in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Nadire xD Zenver und 3 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
xD Zenver, N., Saeed, M., Demirezer, L. X. T. X. M., & Efferth, T. (2026). Correction: Aloeemodin as drug candidate for cancer therapy. Oncotarget, 17(1), 214-215. https://doi.org/10.18632/oncotarget.28870
Vancouver
xD Zenver N, Saeed M, Demirezer LXTXM, Efferth T. Correction: Aloeemodin as drug candidate for cancer therapy. Oncotarget. 2026;17(1):214-215. doi:10.18632/oncotarget.28870
BibTeX
@article{xDZenver2026,
author = {xD Zenver, Nadire and Saeed, Mohamed and Demirezer, L xFC Tfiye xD Mur and Efferth, Thomas},
title = {Correction: Aloeemodin as drug candidate for cancer therapy},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {214--215},
doi = {10.18632/oncotarget.28870}
}
EUVIMED